Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea: A 52-week randomized trial

OBJECTIVE: To evaluate the efficacy and safety of canagliflozin, a sodium glucose cotransporter 2 inhibitor, compared with sitagliptin in subjects with type 2 diabetes inadequately controlled with metformin plus sulfonylurea. RESEARCH DESIGN AND METHODS: In this 52-week, randomized, double-blind, ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Schernthaner, Guntram, Gross, Jorge L., Rosenstock, Julio, Guarisco, Michael, Fu, Min, Yee, Jacqueline, Kawaguchi, Masato, Canovatchel, William, Meininger, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747923/
https://www.ncbi.nlm.nih.gov/pubmed/23564919
http://dx.doi.org/10.2337/dc12-2491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747923/
https://www.ncbi.nlm.nih.gov/pubmed/23564919
http://dx.doi.org/10.2337/dc12-2491

Ejemplares similares